Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric P Winer

Showing results (1-10 of 464) with videos related to

Pageof 47
Sort By:
The New England Journal of Medicine|June 20, 2020
Therapy for HER2-Positive Metastatic Breast Cancer. ReplyEric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Optimizing endocrine therapy for breast cancerEric P Winer
Oncology (Williston Park, N.Y.)|November 18, 2015
POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast CancerShom Goel, Eric P Winer
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant chemotherapy in luminal breast cancersElgene Lim, Eric P Winer
JAMA Oncology|December 13, 2019
De-escalating Breast Cancer Surgery-Where Is the Tipping Point?Monica Morrow, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2013
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerIan Krop, Eric P Winer
The Lancet. Oncology|January 10, 2012
Further progress in HER2-directed therapyIan Krop, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Lumping versus splitting: the splitters take this roundCraig A Bunnell, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Fertility after breast cancer: questions aboundAnn H Partridge, Eric P Winer
Women'S Health (London, England)|October 7, 2009
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancerJennifer A Ligibel, Eric P Winer
Pageof 47

Showing results (1-10 of 464) with videos related to

Sort By:
Pageof 47
The New England Journal of Medicine|June 20, 2020
Therapy for HER2-Positive Metastatic Breast Cancer. ReplyEric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2005
Optimizing endocrine therapy for breast cancerEric P Winer
Oncology (Williston Park, N.Y.)|November 18, 2015
POINT: HER2-Targeted Combinations in Advanced HER2-Positive Breast CancerShom Goel, Eric P Winer
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant chemotherapy in luminal breast cancersElgene Lim, Eric P Winer
JAMA Oncology|December 13, 2019
De-escalating Breast Cancer Surgery-Where Is the Tipping Point?Monica Morrow, Eric P Winer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2013
Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancerIan Krop, Eric P Winer
The Lancet. Oncology|January 10, 2012
Further progress in HER2-directed therapyIan Krop, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2002
Lumping versus splitting: the splitters take this roundCraig A Bunnell, Eric P Winer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2005
Fertility after breast cancer: questions aboundAnn H Partridge, Eric P Winer
Women'S Health (London, England)|October 7, 2009
Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancerJennifer A Ligibel, Eric P Winer
Pageof 47